Joseph C. Papa

Filings by Joseph C. Papa span 9 companies, the busiest being Perrigo Co, Bausch Health Companies Inc. and PERRIGO Co plc. We count 209 filings; the first trade dates from 9 October 2006 and the latest from 29 April 2026.

Market trades split into 9 purchases (€7.2M) and 71 sales (€32.7M). On balance, insiders were net sellers of €25.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 57 share grants and 55 option exercises.

Half of the purchases are above €390k and half below. Clusters matter here: 6 out of 9 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 1 May 2026 came the latest disclosure, a share grant in Emergent BioSolutions Inc. The most recent open-market purchase was published on 15 May 2025, 527 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.